Skip to main content
All lobbying filings

NOVAVAX, INC

Lobbying for NOVAVAX, INC

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$190,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Maryland

Official filing document

 Government bodies contacted 4
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Health Issues

Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks Reauthorization of Pandemic and All-Hazards Preparedness Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem